LFA
RMD icon

Legacy Financial Advisors’s ResMed RMD Stock Holding History

Legacy Financial Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-278
Closed -$29K – 730
2019
Q1 		$29K Buy
278
+178
+178% +$18.4K 0.01% 381
2018
Q4 		$11K Buy
100
+16
+19% +$1.71K ﹤0.01% 547
2018
Q3 		$9K Hold
84
– – ﹤0.01% 555
2018
Q2 		$9K Sell
84
-6
-7% -$607 ﹤0.01% 558
2018
Q1 		$8K Buy
90
+26
+41% +$2.46K ﹤0.01% 545
2017
Q4 		$5K Buy
+64
New +$5.29K ﹤0.01% 638

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Legacy Financial Advisors's RMD Position: Q2 2019 in Review

Legacy Financial Advisors sold out of ResMed (RMD) in Q2 2019, closing a stake of 278 shares — an estimated $29K sold.

Legacy Financial Advisors first reported a position in RMD in Q4 2017 and held it in 6 quarters. The position peaked at $29K in Q1 2019. 485 funds tracked by Wall St. Rank hold RMD as of Q2 2019.

  • Legacy Financial Advisors reported no remaining ResMed position as of Q2 2019 after selling out during the quarter.
  • Legacy Financial Advisors sold 278 ResMed shares in Q2 2019, an estimated $29K.
  • Legacy Financial Advisors first reported a position in ResMed in Q4 2017 and held it in 6 quarters.
  • Legacy Financial Advisors's ResMed position peaked at $29K in Q1 2019.
  • 485 funds tracked by Wall St. Rank held ResMed as of Q2 2019.

Based on Legacy Financial Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.